Effect of Inhibition of Fatty Acid Oxidation on Neonatal Liver Carnitine Content
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The hypoglycaemic agent 2-tetradecylglycidic acid (compound McN-3802) caused an increase in total liver carnitine content, this being due primarily to an increase in the free carnitine pool. In the neonatal animal, this may represent a mechanism to overcome the inhibitory effect of fatty acid oxidation by the drug.
References
1.
McGarry J, Foster D
. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res. 1976; 17(3):277-81.
View
2.
Pearson D, Tubbs P
. Carnitine and derivatives in rat tissues. Biochem J. 1967; 105(3):953-63.
PMC: 1198413.
DOI: 10.1042/bj1050953.
View
3.
Carter A, Frenkel R
. The role of the kidney in the biosynthesis of carnitine in the rat. J Biol Chem. 1979; 254(21):10670-4.
View
4.
Pegorier J, Ferre P, Girard J
. The effects of inhibition of fatty acid oxidation in suckling newborn rats. Biochem J. 1977; 166(3):631-4.
PMC: 1165049.
DOI: 10.1042/bj1660631.
View
5.
Frost S, Wells M
. A comparison of the utilization of medium and long-chain fatty acids for oxidation and ketogenesis in the suckling rat: in vivo and in vitro studies. Arch Biochem Biophys. 1981; 211(2):537-46.
DOI: 10.1016/0003-9861(81)90488-4.
View